SAO •
Healthcare •
Diagnostics & Research •
Quote as of 08/21/2026
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeSAO
Market Capitalization10,155 mln
Float242 mln
Earnings Date11/05/2026
EPS
1.16
Moderate
P / E
16.10
Moderately valued
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.8
Likely reliable
1-Year Forecast
17.63
Limited downside
Relative Strength
70
/ 100
Outperforming
Business Description
Founded in 1926 and based in São Paulo, Fleury S.A. is one of Brazil's leading healthcare companies, offering a broad range of medical services that include diagnostic imaging, laboratory analysis, fertility treatments, and drug infusion therapy. The company also supports patients through telemedicine, oncology research, genomics, and ophthalmology care. With nearly a century of experience, Fleury continues to expand its reach across both diagnostic and integrated medicine.
